Testing Epidermal Growth Factor Receptor Mutations in Patients With Non-Small-Cell Lung Cancer to Choose Chemotherapy: The Other Side of the Coin

被引:13
作者
Garassino, Marina Chiara [1 ]
Marsoni, Silvia [2 ]
Floriani, Irene [3 ]
机构
[1] Fatebenefratelli & Ophthalm Hosp, Milan, Italy
[2] So European New Drugs Org Fdn, Milan, Italy
[3] Mario Negri Inst Pharmacol Res, Milan, Italy
关键词
PHASE-III; GEFITINIB; ADENOCARCINOMAS; DOCETAXEL;
D O I
10.1200/JCO.2011.36.7847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3835 / 3837
页数:3
相关论文
共 9 条
[1]   Genetic Testing for Lung Cancer: Reflex Versus Clinical Selection [J].
Bunn, Paul A., Jr. ;
Doebele, Robert C. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :1943-1945
[2]  
Ciuleanu T, 2010, CHIC MULT S THOR ONC
[3]   Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas [J].
D'Angelo, Sandra P. ;
Pietanza, M. Catherine ;
Johnson, Melissa L. ;
Riely, Gregory J. ;
Miller, Vincent A. ;
Sima, Camelia S. ;
Zakowski, Maureen F. ;
Rusch, Valerie W. ;
Ladanyi, Marc ;
Kris, Mark G. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :2066-2070
[4]   American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy [J].
Keedy, Vicki Leigh ;
Temin, Sarah ;
Somerfield, Mark R. ;
Beasley, Mary Beth ;
Johnson, David H. ;
McShane, Lisa M. ;
Milton, Daniel T. ;
Strawn, John R. ;
Wakelee, Heather A. ;
Giaccone, Giuseppe .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :2121-2127
[5]   Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial [J].
Kim, Edward S. ;
Hirsh, Vera ;
Mok, Tony ;
Socinski, Mark A. ;
Gervais, Radj ;
Wu, Yi-Long ;
Li, Long-Yun ;
Watkins, Claire L. ;
Sellers, Mark V. ;
Lowe, Elizabeth S. ;
Sun, Yan ;
Liao, Mei-Lin ;
Osterlind, Kell ;
Reck, Martin ;
Armour, Alison A. ;
Shepherd, Frances A. ;
Lippman, Scott M. ;
Douillard, Jean-Yves .
LANCET, 2008, 372 (9652) :1809-1818
[6]   Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer [J].
Maruyama, Riichiroh ;
Nishiwaki, Yutaka ;
Tamura, Tomohide ;
Yamamoto, Nobuyuki ;
Tsuboi, Masahiro ;
Nakagawa, Kazuhiko ;
Shinkai, Tetsu ;
Negoro, Shunichi ;
Imamura, Fumio ;
Eguchi, Kenji ;
Takeda, Koji ;
Inoue, Akira ;
Tomii, Keisuke ;
Harada, Masao ;
Masuda, Noriyuki ;
Jiang, Haiyi ;
Itoh, Yohji ;
Ichinose, Yukito ;
Saijo, Nagahiro ;
Fukuoka, Masahiro .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4244-4252
[7]   Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. [J].
Mok, Tony S. ;
Wu, Yi-Long ;
Thongprasert, Sumitra ;
Yang, Chih-Hsin ;
Chu, Da-Tong ;
Saijo, Nagahiro ;
Sunpaweravong, Patrapim ;
Han, Baohui ;
Margono, Benjamin ;
Ichinose, Yukito ;
Nishiwaki, Yutaka ;
Ohe, Yuichiro ;
Yang, Jin-Ji ;
Chewaskulyong, Busyamas ;
Jiang, Haiyi ;
Duffield, Emma L. ;
Watkins, Claire L. ;
Armour, Alison A. ;
Fukuoka, Masahiro .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) :947-957
[8]   Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations [J].
Paik, Paul K. ;
Arcila, Maria E. ;
Fara, Michael ;
Sima, Camelia S. ;
Miller, Vincent A. ;
Kris, Mark G. ;
Ladanyi, Marc ;
Riely, Gregory J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :2046-2051
[9]   Erlotinib in previously treated non-small-cell lung cancer [J].
Shepherd, FA ;
Pereira, JR ;
Ciuleanu, T ;
Tan, EH ;
Hirsh, V ;
Thongprasert, S ;
Campos, D ;
Maoleekoonpiroj, S ;
Smylie, M ;
Martins, R ;
van Kooten, M ;
Dediu, M ;
Findlay, B ;
Tu, DS ;
Johnston, D ;
Bezjak, A ;
Clark, G ;
Santabárbara, P ;
Seymour, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132